Shareholders Turn Down Tender Offer to Take BioCanCell Private Post author:Sam Post published:December 27, 2017 Post category:BioPharma Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace You Might Also Like AcelRx Stopped Cold: FDA Rejects NDA for Pain Drug Dsuvia (ARX-04) October 11, 2017 Worldwide Clinical Trials Selects " As New Head Of Global Business Development March 29, 2017 Gilead Commits $100M to Tackle the HIV/AIDS Epidemic in the Southern U.S. December 3, 2017
